Muted stock reaction to new battery order

Enovix (ENVX) recently announced a new battery order, but the stock reaction has been muted as investors weigh ongoing concerns about sustained demand and slow progress in drone battery applications over recent quarters.

Against this muted reaction to the new order, Enovix’s recent share price performance has been mixed, with a 46.28% 90 day share price return but a year to date share price decline of 10.27% and a 1 year total shareholder return decline of 16.11%. This suggests short term momentum alongside longer term caution.

If this kind of rebound-to-reassessment pattern interests you, it could be a good moment to see what else is setting up in AI infrastructure, starting with the 48 AI infrastructure stocks.

With Enovix posting mixed returns, securing a recent battery order, and holding a market value of about US$1.42b against analyst price targets that sit higher, the key question is simple: is this stock undervalued, or is the market already pricing in future growth?

Most Popular Narrative: 46% Undervalued

At a last close of $7.08 versus a narrative fair value of $13.10, Enovix is framed as materially undervalued, with that gap resting on some punchy growth assumptions.

Upcoming high-volume production and next-gen battery advancements signal potential revenue and earnings growth aligned with 2025 smartphone and AR/VR launches.

Read the complete narrative. Read the complete narrative.

Want to see what sits behind that valuation gap? The central storyline leans on steep revenue expansion, a swing from heavy losses to profits, and a premium future earnings multiple. Curious how those ingredients combine to support a fair value above today’s Enovix share price? The full narrative lays out the exact path management and analysts are modelling.

Result: Fair Value of $13.10 (UNDERVALUED)

However, the Enovix narrative still hinges on successful smartphone qualification and the scaling of high-volume production, where delays or manufacturing setbacks could quickly challenge those optimistic assumptions.

Another view on Enovix stock valuation

The fair value narrative for Enovix paints the shares as 46% undervalued, but the current P/S ratio of 43.9x tells a different story. That compares with 2.5x for the US Electrical industry, 13.5x for peers, and a fair ratio of 5.8x. This points to meaningful valuation risk if expectations cool.

To see what the numbers say about this price in more detail, it is worth reviewing the valuation breakdown in the See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

Unsure how to balance the concerns and the potential around Enovix after this latest update? Review the underlying data, act while sentiment is still forming, and weigh both the 1 key reward and 1 important warning sign.

Looking for more investment ideas beyond Enovix?

If Enovix has you thinking more broadly about where to put fresh capital to work, it is worth lining up a few alternatives before the next move in sentiment.

• Target potential upside in overlooked corners of the market by scanning screener containing 20 high quality undiscovered gems that pair solid fundamentals with limited investor attention.
• Prioritise resilience by reviewing 68 resilient stocks with low risk scores that score well on stability so your portfolio is not relying on a single story.
• Strengthen your core holdings by focusing on companies in the solid balance sheet and fundamentals stocks screener (48 results) that can better handle shocks without urgent capital raises.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.